akt mutant plasmid (Addgene inc)
Structured Review
Akt Mutant Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna3+t7+akt1/1014+pcDNA3+T7+Akt1+K179M+T308A+S473A+(Plasmid+%239031)/pm33370582-73-0-10
Average 93 stars, based on 12 article reviews
Images
Related Articles
Plasmid Preparation:Article Title: MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent. Article Snippet: .. pcDNA3.1-HA-V5/His plasmid was constructed by inserting a synthetic oligonucleotides duplex encoding an HA tag between the KpnI and BamHI sites of pcDNA3.1-V5/His (A) (Thermo Fisher Scientific). pcDNA3.1-HA-AKT1-WT-V5/His was constructed by subcloning the BamHI-EcoRI fragment from Article Title: Phospholipase D 2 Mediates Survival Signaling through Direct Regulation of Akt in Glioblastoma Cells Article Snippet: .. Plasmids and Baculovirus Production The following plasmids were obtained from Article Title: SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. Article Snippet: The remaining part was amplified with 30 bp overhangs and assembled by homologous recombination in yeast as described below and the resulting construct was verified by Sanger sequencing (Genewiz). .. For transient overexpression of Akt1-wt-HA, DNA was amplified (DNA from 896 Article Title: Phospholipase D 2 Mediates Survival Signaling through Direct Regulation of Akt in Glioblastoma Cells Article Snippet: .. The following plasmids were obtained from Construct:Article Title: MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent. Article Snippet: .. pcDNA3.1-HA-V5/His plasmid was constructed by inserting a synthetic oligonucleotides duplex encoding an HA tag between the KpnI and BamHI sites of pcDNA3.1-V5/His (A) (Thermo Fisher Scientific). pcDNA3.1-HA-AKT1-WT-V5/His was constructed by subcloning the BamHI-EcoRI fragment from Subcloning:Article Title: MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent. Article Snippet: .. pcDNA3.1-HA-V5/His plasmid was constructed by inserting a synthetic oligonucleotides duplex encoding an HA tag between the KpnI and BamHI sites of pcDNA3.1-V5/His (A) (Thermo Fisher Scientific). pcDNA3.1-HA-AKT1-WT-V5/His was constructed by subcloning the BamHI-EcoRI fragment from Over Expression:Article Title: SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. Article Snippet: The remaining part was amplified with 30 bp overhangs and assembled by homologous recombination in yeast as described below and the resulting construct was verified by Sanger sequencing (Genewiz). .. For transient overexpression of Akt1-wt-HA, DNA was amplified (DNA from 896 Amplification:Article Title: SH3BP4 promotes neuropilin-1 and α5-integrin endocytosis and is inhibited by Akt. Article Snippet: The remaining part was amplified with 30 bp overhangs and assembled by homologous recombination in yeast as described below and the resulting construct was verified by Sanger sequencing (Genewiz). .. For transient overexpression of Akt1-wt-HA, DNA was amplified (DNA from 896 |




![AKT-mediated phosphorylation on MASTL increases CDK1 substrate phosphorylation. (A) pCMV-HA-MASTL (2 μg) was cotransfected with <t>pCDNA3.1-HA-AKT</t> (1 μg) into HEK 293T cells, and pEGFP-F (1 μg) was used as a transfection control. At 24 h posttransfection, cells were arrested in mitosis by use of 50 nM nocodazole for 18 h. Western blotting showed a band shift of HA-MASTL in the presence of HA-AKT (indicated by the arrow). (B) Increasing amounts of pCDNA3.1-HA-AKT were cotransfected with pCMV-HA-MASTL (2 μg) into 293T cells. The blot shows increasing phosphorylation of MASTL as well as other CDK substrates in the presence of increasing amounts of HA-AKT. Phosphorylation levels of Aurora kinase (pAur) were used as mitotic markers. For blots below the dashed line, the same lysates as those above the line were loaded again and run on a separate gel. (D) Western blot showing CDK-mediated phosphorylation of mutant MASTL (mutMASTL) or other CDK substrates in the presence of increasing amounts of HA-AKT. (F) An antibody against phospho-CDK1-T14 (pThr14) was used to determine PP2A activity in the presence of the cotransfected constructs HA-MASTL (2 μg) and <t>HA-AKT1</t> (in increasing amounts [0.25, 0.5. 0.75, 1.0, and 1.5 μg in the second to sixth lanes, respectively]). The amounts of transfected HA-AKT were detected using an anti-AKT antibody, while MASTL was detected with an anti-MASTL antibody. (G) Blot showing CDK1 substrate phosphorylation levels in the presence of wild-type HA-MASTL (2 μg) and increasing amounts of pKH3-RSK1. (C, E, and H) Quantification of the anti-pSer-CDK1 substrate signal intensities in panels B, D, and G, respectively. The amounts of transfected plasmids used in panels B, D, and G are given in panels C, E, and H, respectively. The experiments were repeated three times. Data are expressed as means ± standard errors of the means of triplicates.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_9101/pmc07189101/pmc07189101__MCB.00366-18-f0004.jpg)